跳至主要内容
临床试验/ACTRN12622001488796
ACTRN12622001488796尚未招募未知

Can early referral to allied health impact on hospital admissions and quality of life after diagnosis of high grade glioma?

Dr Kristie Harper0 个研究点目标入组 124 人开始时间: 2022年11月28日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Dyads consisting of patients, and their carer, will be eligible if they are aged 18 years or older and the patient is diagnosed with HGG (including Grade III anaplastic astrocytomas, Grade III oligodendrogliomas and glioblastoma]) within the past three months.
  • Patients without a carer will still be eligible for inclusion.

排除标准

  • Patient or carers who are unable to provide informed consent to participate in the study.

研究者

发起方
Dr Kristie Harper

相似试验